Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2 pseudogene 29 (MTND2P29)
- Target
- MTND2P29
- Molecular classification
- Other (Pseudogene)
01
Overview
MTND2P29 is a pseudogene listed in human genomics databases. It is a nuclear pseudogene related to the mitochondrial MT-ND2 gene, which codes for a core subunit of the mitochondrial electron transport chain complex I (NADH:ubiquinone oxidoreductase). Unlike the functional MT-ND2 gene, which plays a crucial role in mitochondrial energy metabolism and is implicated in several mitochondrial diseases, MTND2P29 is not known to produce a functional protein, is not implicated in disease, and is not targeted by any known drugs. As a pseudogene, it is generally considered non-functional, and there is no evidence of its involvement in human disease, therapy, or physiology[2][4][6].
- Other names
- MT-ND2 pseudogene 29MTND2P29
02
Biological functions
None confirmed; as a pseudogene, there is no established protein product or function. Pseudogenes may occasionally have regulatory or other roles, but no such roles are established for MTND2P29.
03
Disease associations
None established. There are no published associations of MTND2P29 with diseases, in contrast to the functional MT-ND2 gene.
Beyond the preview
Go deeper on Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2 pseudogene 29 (MTND2P29).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2 pseudogene 29 (MTND2P29).